Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > EBIT

Amneal Pharmaceuticals Inc EBIT Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly EBIT from 2016 to 2018. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Amneal Pharmaceuticals Inc EBIT for the quarter ending December 12, 2018 was $62m a -14.88% decrease of -9m year over year
  • Amneal Pharmaceuticals Inc EBIT for the last 12 months ending December 12, 2018 was $276m a -0.49% decrease of -1m year over year
  • Amneal Pharmaceuticals Inc Annual EBIT for 2018 was $276m a 9.71% increase of 27m from 2017
  • Amneal Pharmaceuticals Inc Annual EBIT for 2017 was $249m a -10.04% decrease of -25m from 2016
  • Amneal Pharmaceuticals Inc Annual EBIT for 2016 was $274m a 16.99% increase of 47m from 2015
Other Income Statement Metrics:
  • Amneal Pharmaceuticals Inc EBITDA for the quarter ending December 12, 2018 was $109m a 21.60% increase of 24m year over year
  • Amneal Pharmaceuticals Inc Net Income for the quarter ending December 12, 2018 was $-9m a 687.76% decrease of -60m year over year
  • Amneal Pharmaceuticals Inc Total Revenue for the quarter ending December 12, 2018 was $498m a 44.69% increase of 222m year over year
View Chart On Koyfin

Quarterly AMRX EBIT Data

12/2018$62m
09/2018$93m
06/2018$71m
03/2018$71m
12/2017$82m
09/2017$60m
06/2017$45m
03/2017$43m
12/2016$93m

Annual AMRX EBIT Data

2018$276m
2017$249m
2016$274m
2015$227m
2014$223m